271 related articles for article (PubMed ID: 26315089)
1. Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.
Yi B; Huang G; Zhou ZG
Chin Med J (Engl); 2015 Sep; 128(17):2387-94. PubMed ID: 26315089
[TBL] [Abstract][Full Text] [Related]
2. ZnT8 and type 1 diabetes.
Kawasaki E
Endocr J; 2012; 59(7):531-7. PubMed ID: 22447136
[TBL] [Abstract][Full Text] [Related]
3. Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus.
Yi B; Huang G; Zhou Z
J Diabetes Investig; 2016 Jul; 7(4):459-65. PubMed ID: 27181765
[TBL] [Abstract][Full Text] [Related]
4. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
[TBL] [Abstract][Full Text] [Related]
5. Prediction and prevention of Type 1 diabetes mellitus.
Zhang L; Eisenbarth GS
J Diabetes; 2011 Mar; 3(1):48-57. PubMed ID: 21073664
[TBL] [Abstract][Full Text] [Related]
6. Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination.
Yu L; Liu Y; Miao D; Wenzlau J; Davidson H; Hutton J; Eisenbarth GS
J Immunol Methods; 2010 Feb; 353(1-2):20-3. PubMed ID: 20035758
[TBL] [Abstract][Full Text] [Related]
7. Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus.
Dunseath G; Ananieva-Jordanova R; Coles R; Powell M; Amoroso M; Furmaniak J; Smith BR; Dayan C; Luzio S
Clin Chim Acta; 2015 Jul; 447():90-5. PubMed ID: 26006309
[TBL] [Abstract][Full Text] [Related]
8. What has zinc transporter 8 autoimmunity taught us about type 1 diabetes?
Williams CL; Long AE
Diabetologia; 2019 Nov; 62(11):1969-1976. PubMed ID: 31444530
[TBL] [Abstract][Full Text] [Related]
9. ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.
Énée É; Kratzer R; Arnoux JB; Barilleau E; Hamel Y; Marchi C; Beltrand J; Michaud B; Chatenoud L; Robert JJ; van Endert P
Diabetes; 2012 Jul; 61(7):1779-84. PubMed ID: 22586580
[TBL] [Abstract][Full Text] [Related]
10. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
[TBL] [Abstract][Full Text] [Related]
11. Novel antigens in type 1 diabetes: the importance of ZnT8.
Wenzlau JM; Frisch LM; Gardner TJ; Sarkar S; Hutton JC; Davidson HW
Curr Diab Rep; 2009 Apr; 9(2):105-12. PubMed ID: 19323954
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.
Achenbach P; Lampasona V; Landherr U; Koczwara K; Krause S; Grallert H; Winkler C; Pflüger M; Illig T; Bonifacio E; Ziegler AG
Diabetologia; 2009 Sep; 52(9):1881-8. PubMed ID: 19590848
[TBL] [Abstract][Full Text] [Related]
13. New antigenic targets in type 1 diabetes.
Wenzlau JM; Hutton JC; Davidson HW
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):315-20. PubMed ID: 18594270
[TBL] [Abstract][Full Text] [Related]
14. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?
Rogowicz-Frontczak A; Zozuliłska-Ziołkiewicz D; Litwinowicz M; Niedźwiecki P; Wyka K; Wierusz-Wysocka B
Eur J Endocrinol; 2014 Apr; 170(4):651-8. PubMed ID: 24480135
[TBL] [Abstract][Full Text] [Related]
15. In silico identification and wet lab validation of novel cryptic B cell epitopes in ZnT8 zinc transporter autoantigen.
Shruthi S; Mohan V; Maradana MR; Aravindhan V
Int J Biol Macromol; 2019 Apr; 127():657-664. PubMed ID: 30710592
[TBL] [Abstract][Full Text] [Related]
16. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype.
Trabucchi A; Faccinetti NI; Guerra LL; Puchulu FM; Frechtel GD; Poskus E; Valdez SN
Autoimmunity; 2012 Mar; 45(2):137-42. PubMed ID: 21875382
[TBL] [Abstract][Full Text] [Related]
18. The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.
Petruzelkova L; Ananieva-Jordanova R; Vcelakova J; Vesely Z; Stechova K; Lebl J; Dusatkova P; Sumnik Z; Coles R; Powell M; Furmaniak J; Rees Smith B; Kolouskova S
Diabet Med; 2014 Feb; 31(2):165-71. PubMed ID: 23952619
[TBL] [Abstract][Full Text] [Related]
19. Zinc transporter 8 autoantibodies (ZnT8-ab) are associated with higher prevalence of multiple diabetes-related autoantibodies in adults with type 1 diabetes.
Rogowicz-Frontczak A; Pilacinski S; Wyka K; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
Diabetes Res Clin Pract; 2018 Dec; 146():313-320. PubMed ID: 30465779
[TBL] [Abstract][Full Text] [Related]
20. Anti-Zinc Transporter Protein 8 Antibody Testing Is Not Informative in Routine Prediabetes Screening in Young Patients with Autoimmune Thyroiditis and Celiac Disease.
Larizza D; De Amici M; Klersy C; Albanesi M; Albertini R; Badulli C; Torre C; Calcaterra V
Horm Res Paediatr; 2016; 86(2):100-105. PubMed ID: 27487045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
